Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

4th Jan 2016 15:55

RNS Number : 7694K
GlaxoSmithKline PLC
04 January 2016
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

 

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc (the 'Company').

 

On 31 December 2015, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £13.83 per Ordinary Share, and notional ADSs at a price of $40.98 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2015 to 31 December 2015:

 

Non Executive Director

Ordinary Shares

No. of ADSs

Sir Philip Hampton

3,163.413

Professor Sir Roy Anderson

655.278

Vindi Banga

1,536.515

Dr Stephanie Burns

410.403

Stacey Cartwright

519.704

Lynn Elsenhans

912.543

Judy Lewent

398.332

Sir Deryck Maughan

1,110.502

Dr Daniel Podolsky

832.877

Urs Rohner

610.087

Hans Wijers

519.704

In addition, on 31 December 2015, Mr Banga was allocated 566.213 notional Ordinary Shares at a price of £12.51 per Ordinary Share in respect of the period of service from 1 September 2015 to 30 September 2015.

 

The Company and the Non-Executive Directors were informed of these allocations on 4 January 2016.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

4 January 2016

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEZLFBQFFEBBL

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77